In line with these findings, it has recently been postulated that low ROS levels in RA patient derived T-cells connects cellular metabolism with auto-aggressive T-cell immunity including biased differentiation of T-cells into IFN-γ and IL-17-producing inflammatory cells (18). The gene discussed is IL17A; the disease is rheumatoid arthritis.